Kailera
Clinical trials sponsored by Kailera, explained in plain language.
-
New weekly shot aims to tackle weight and diabetes in major trial
Disease control Recruiting nowThis study is testing if a new weekly injection called KAI-9531 is better than a placebo at helping people lose weight and improve their blood sugar control. It will involve about 1,700 adults who have type 2 diabetes and are also overweight or have obesity. The main goal is to s…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
New weekly shot aims to outperform leading Weight-Loss drug
Disease control Recruiting nowThis study is testing a new weekly injection called KAI-9531 to see if it helps people with obesity lose more weight than a current medication (semaglutide) or a placebo (inactive shot). It will involve about 1200 adults who do not have diabetes. The main goal is to see which tre…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Weekly shot aims to help millions shed pounds in major trial
Disease control Recruiting nowThis study is testing a new weekly injection called KAI-9531 to see if it helps people with obesity or overweight lose weight and improve related health issues like high blood pressure or cholesterol. About 1,800 adults who have struggled to lose weight through diet and exercise …
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC